Skip to search formSkip to main contentSkip to account menu

Bleomycin/Prednisone/Vincristine regimen (BOP)

Known as: BLEO/PRED/VCR, BOP, Bleomycin/Prednisone/Vincristine 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2012
Review
2012
Aim A double-blind randomized controlled trial to determine whether dietary supplementation with fruit/vegetable/berry juice… 
Highly Cited
2011
Highly Cited
2011
AIM The objective was to determine clinical and microbiological effects and perceived treatment discomfort of root debridement by… 
Highly Cited
2002
Highly Cited
2002
BACKGROUND Our research group has recently reported that exogenously applied histatins can inhibit plaque accumulation and… 
Highly Cited
1998
Highly Cited
1998
PURPOSE The aim of this randomized trial was to assess the potential therapeutic advantage of an intensive induction-sequential… 
Highly Cited
1996
Highly Cited
1996
The chemopreventive effects of phenethyl isothiocyanate (PEITC) were investigated in N-nitrosobis(2-oxopropyl)-amine (BOP… 
Highly Cited
1993
Highly Cited
1993
The presence of K‐ras gene mutation was examined in experimentally induced preneoplastic pancreatic ductal lesions. Syrian… 
Highly Cited
1989
Highly Cited
1989
Female Syrian golden hamsters with N-nitrosobis(2-oxopropyl)amine (BOP)-induced ductal pancreatic cancers were treated with long… 
Highly Cited
1989
Highly Cited
1989
Membrane receptors for [D-Trp6]-luteinizing hormone-releasing hormone ([D-Trp6-LH-RH), somatostatin (SS-14), and epidermal growth… 
Highly Cited
1985
Highly Cited
1985
The role of the pancreaticotrophic hormone cholecystokinin (CCK) in modifying the pancreatic response to carcinogen has been…